Axovant Sciences Ltd (AXGT) Stock Price & Overview

NASDAQ:AXGT

2.1

-0.05 (-2.33%)

At close: Nov 12, 2020

2.1

0 (0%)

After Hours: 11/12/2020, 8:00:01 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of AXGT is 2.1 null. Today AXGT is down by -2.33%. In the past month the price decreased by -38.95%. In the past year, price decreased by -55.32%.

AXGT Key Statistics

52-Week Range1.41 - 6.12

1-Month Range1.86 - 3.95

Market Cap: 99.225M
P/E: N/A
Fwd P/E: N/A
EPS (TTM): -1.97
Dividend Yield: N/A

AXGT Stock Performance

Today

-2.33%

1 Week

-5.41%

1 Month

-38.95%

3 Months

-31.15%

Longer-term

6 Months -33.75%

1 Year -55.32%

2 Years N/A

3 Years N/A

5 Years N/A

10 Years N/A

AXGT Stock Chart

Axovant Sciences Ltd / AXGT Daily stock chart

AXGT Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to AXGT. When comparing the yearly performance of all stocks, AXGT is a bad performer in the overall market: 97.83% of all stocks are doing better.

Chartmill TA Rating

Chartmill Setup Rating

AXGT Full Technical Analysis Report

AXGT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AXGT. Both the profitability and financial health of AXGT have multiple concerns.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

AXGT Full Fundamental Analysis Report

AXGT Earnings

Next Earnings DateN/A

Last Earnings DateN/A

AXGT Earnings History

AXGT Forecast & Estimates

Analysts

Analysts92

Price TargetN/A

EPS Next Y63.48%

Revenue Next YearN/A

AXGT Forecast & Estimates

AXGT Financial Highlights

Over the last trailing twelve months AXGT reported a non-GAAP Earnings per Share(EPS) of -1.9699999999999998. The EPS increased by 67.6% compared to the year before.

Income Statements

Revenue(TTM)N/A

Net Income(TTM)-53.16M

		Industry Rank	Sector Rank
PM (TTM)	N/A
ROA	-74.84%
ROE	N/A
Debt/Equity	0.11

Chartmill High Growth Momentum

EPS Q2Q%83.74%

Sales Q2Q%N/A

EPS 1Y (TTM)67.6%

Revenue 1Y (TTM)N/A

AXGT financials

AXGT Ownership

Ownership

Inst Owners0%

Shares47.25M

Float29.49M

Ins Owners39.32%

Short Float %N/A

Short RatioN/A

AXGT Ownership

About AXGT

Company Profile

Axovant Sciences Ltd. is a biopharmaceutical company which focuses on the acquisition, development and commercialization of therapeutics for the treatment of neurodegenerative disorders. Its product candidate includes RVT-101 which is in different clinical trial for the treatment of Alzheimer's disease and other forms of dementia. Axovant Sciences Ltd. is based in Hamilton, Bermuda.

Company Info

Axovant Sciences Ltd

11-12 ST. JAMES`S SQUARE SUITE 1 3RD FLOOR

LONDON X0 10036

CEO: Pavan Cheruvu

Phone: 833-296-8268

Axovant Sciences Ltd / AXGT FAQ

What does Axovant Sciences Ltd do?

What is the stock price of Axovant Sciences Ltd today?

The current stock price of AXGT is 2.1 null. The price decreased by -2.33% in the last trading session.

Does Axovant Sciences Ltd pay dividends?

AXGT does not pay a dividend.

What is the ChartMill technical and fundamental rating of AXGT stock?

AXGT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

Can you provide the PE ratio for AXGT stock?

Axovant Sciences Ltd (AXGT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.97).